tiprankstipranks
pc:hills

Hillstar Bio

Boston, US
https://www.hillstarbio.com/
Hillstar Bio is a biotechnology company specializing in precision immunology therapies aimed at treating autoimmune diseases. The company's innovative approach involves selectively targeting and depleting pathogenic immune cells to potentially reset the immune system, thereby offering more durable therapeutic responses. Hillstar Bio is advancing its lead TRBV9 program through clinical studies for conditions such as axial spondyloarthritis, while also progressing its broader therapeutic pipeline.

Leadership & Board

Current Number of Employees20
Current LinkedIn Followers3,969

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$67M
Total Amount Raised$67M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$67M
Latest Funding Amount$67M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

Hillstar Bio had 20 employees as of March 23, 2026. The number of employees increased by 0 (0.00%) week-over-week.
20Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Hillstar Bio had 3,969 followers as of March 23, 2026. The number of followers increased by 12 (0.30%) week-over-week.
3,969Latest Followers Count
12(0.30%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Mar 25, 2025
Series A
$67.00M

Investors

Investor Name
Funding Round

Related News and Analysis